Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01317914 · ClinicalTrials.gov registry record · NA
Prospective Study of Undiagnosed Celiac Disease
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01317914: Completed NA study, sponsored by Mayo Clinic.
NCT01317914 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01317914, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Direct benefits to the participants, who are diagnosed with celiac disease may be substantial and could include lessening or prevention of GI symptoms, correction of biochemical abnormalities and reduction in risk for malignancies or bone disease which are most common in untreated celiac disease. However, the precise benefit is unknown and the motivation for this proposed study. If these individuals have a positive celiac serology test at the present time there is a high likelihood that they may have celiac disease.
Interventions
- OTHER Dietary instruction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01317914
The ClinicalTrials.gov registry entry for NCT01317914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dietary instruction is the first listed.
NCT01317914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01317914 about?
NCT01317914 is a clinical study titled "Prospective Study of Undiagnosed Celiac Disease". Direct benefits to the participants, who are diagnosed with celiac disease may be substantial and could include lessening or prevention of GI symptoms, correction of biochemical abnormalities and reduction in risk for malignancies or bone disease which are most common in untreated celiac disease. Ho...
What is the current status of trial NCT01317914?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2010-07. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01317914?
The interventions under investigation include: Dietary instruction (OTHER).
Who is sponsoring clinical trial NCT01317914?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.